Literature DB >> 16378512

Animal models of ejaculatory behavior.

T Pattij1, B Olivier, M D Waldinger.   

Abstract

Premature ejaculation is generally regarded the most frequent male ejaculatory complaint and has been considered a psychosexual disorder with psychogenic aetiology. The efficacy of various antidepressants, however, to delay ejaculation in men and to pharmacologically treat premature ejaculation suggests a strong neurobiological involvement. Most of our current understanding of the neurobiology and neuroanatomy of sexual behavior and ejaculatory function has been derived from preclinical studies using several laboratory species. In the present paper we will review the various animal models that have been developed to further study ejaculatory function in the laboratory rat. In addition, we will briefly review the effects of serotonergic antidepressants and serotonergic compounds on sexual and ejaculatory behavior. Together, these preclinical studies may contribute to a better understanding of the neurobiology of ejaculation and help the development of novel drug targets to treat ejaculatory disorders such as premature ejaculation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16378512     DOI: 10.2174/138161205774913363

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  13 in total

1.  Medical therapy for premature ejaculation.

Authors:  Amar Mohee; Ian Eardley
Journal:  Ther Adv Urol       Date:  2011-10

Review 2.  Premature ejaculation: definition and drug treatment.

Authors:  Marcel D Waldinger
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Ejaculatory training lengthens the ejaculation latency and facilitates the functioning of the spinal generator for ejaculation of rats with rapid ejaculation.

Authors:  M de L Rodríguez-Peña; G Rodríguez-Manzo; M Carro-Juárez
Journal:  Int J Impot Res       Date:  2016-10-27       Impact factor: 2.896

4.  Paternal dapoxetine administration induced deterioration in reproductive performance, fetal outcome, sexual behavior and biochemistry of male rats.

Authors:  R ElMazoudy; N AbdelHameed; A ElMasry
Journal:  Int J Impot Res       Date:  2015-09-24       Impact factor: 2.896

5.  Dapoxetine: a new option in the medical management of premature ejaculation.

Authors:  Chris G McMahon
Journal:  Ther Adv Urol       Date:  2012-10

6.  Brain neuronal activation induced by flibanserin treatment in female rats.

Authors:  Helene Gelez; Pierre Clement; Sandrine Compagnie; Diane Gorny; Miguel Laurin; Kelly Allers; Bernd Sommer; Francois Giuliano
Journal:  Psychopharmacology (Berl)       Date:  2013-07-16       Impact factor: 4.530

Review 7.  Current therapeutic strategies for premature ejaculation and future perspectives.

Authors:  Zhong-Cheng Xin; Yi-Chen Zhu; Yi-Ming Yuan; Wan-Shou Cui; Zhe Jin; Wei-Ren Li; Tao Liu
Journal:  Asian J Androl       Date:  2011-05-02       Impact factor: 3.285

Review 8.  The hormonal control of ejaculation.

Authors:  Giovanni Corona; Emmanuele A Jannini; Linda Vignozzi; Giulia Rastrelli; Mario Maggi
Journal:  Nat Rev Urol       Date:  2012-08-07       Impact factor: 14.432

9.  Efficacy of dapoxetine in the treatment of premature ejaculation.

Authors:  Chris G McMahon
Journal:  Clin Med Insights Reprod Health       Date:  2011-08-02

10.  The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy: The PASSION Study.

Authors:  Chris McMahon; Sung Won Lee; Sae Woong Kim; Du Geon Moon; Apichat Kongkanand; Kavirach Tantiwongse
Journal:  Sex Med       Date:  2016-03       Impact factor: 2.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.